Insider Transactions in Q2 2025 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 10
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.17%
|
$180,000
$36.77 P/Share
|
|
Apr 08
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.41%
|
$72,000
$36.18 P/Share
|
|
Apr 08
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.39%
|
$20,000
$10.6 P/Share
|
|
Apr 07
2025
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,886
-4.27%
|
$101,010
$35.78 P/Share
|
|
Apr 03
2025
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
450
-2.98%
|
$17,550
$39.43 P/Share
|